Oxford BioDynamics Plc Revenue and Competitors

Oxford, UK

Location

N/A

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • Oxford BioDynamics Plc's estimated annual revenue is currently $9.8M per year.(i)
  • Oxford BioDynamics Plc's estimated revenue per employee is $153,000

Employee Data

  • Oxford BioDynamics Plc has 64 Employees.(i)
  • Oxford BioDynamics Plc grew their employee count by 33% last year.

Oxford BioDynamics Plc's People

NameTitleEmail/Phone
1
CSOReveal Email/Phone
2
COOReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
VP Clinical DiagnosticsReveal Email/Phone
5
Head Human Resources UKReveal Email/Phone
6
Clinical Customer Service, DirectorReveal Email/Phone
7
Director OperationsReveal Email/Phone
8
Senior Director, Commercial DevelopmentReveal Email/Phone
9
CEO, DirectorReveal Email/Phone
10
Associate Director RAQAReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.6M41-11%N/AN/A
#2
$3.3M2817%N/AN/A
#3
$6.7M49N/AN/AN/A
#4
$3.1M26N/AN/AN/A
#5
$2.4M20-55%N/AN/A
#6
$8.6M5647%N/AN/A
#7
$4.1M30-21%N/AN/A
#8
$38.9M20825%N/AN/A
#9
$6.8M50-17%N/AN/A
#10
$421.5M177113%N/AN/A
Add Company

What Is Oxford BioDynamics Plc?

Oxford BioDynamics Ltd (OBD) is a health-care service company with a proprietary biomarker discovery platform, EpiSwitch™, based on the latest advances in the mechanisms of gene expression, non-coding RNA and epigenetics. The EpiSwitch™ biomarker discovery platform offers a highly effective means of new product development for applications in screening, early detection, monitoring and prognosis of disease and chronic conditions associated with aberrant gene expression such as oncology, inflammatory, auto-immune, metabolic, cardiovascular and neurodegenerative conditions. Products developed on the basis of the proprietary EpiSwitch™ biomarker discovery platform offer a broad spectrum of applications such as: - Predictive Biomarkers - Prognostic Biomarkers - Companion Diagnostics - Diagnostics The Oxford BioDynamics holding company is registered in England and Wales, and has reference laboratory in Oxford, UK and Penang, Malaysia.

keywords:N/A

N/A

Total Funding

64

Number of Employees

$9.8M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oxford BioDynamics Plc News

2022-04-17 - Nucleome Therapeutics appoints Dr Phil Boyd as Chief Financial Officer

... Tiziana Lifesciences plc taking it through its IPO in April 2014, and Oxford BioDynamics in preparation for its IPO in December 2016.

2022-03-22 - Oxford BioDynamics Announces US Launch of Its Checkpoint ...

OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine...

2022-03-22 - Oxford Biodynamics launches immune checkpoint inhibitor test in US

Oxford Biodynamics plc is launching its clinical assay Episwitch CIRT in the U.S. following clinical validation that demonstrated the 3D...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.6M6439%N/A
#2
$8.4M64-33%N/A
#3
N/A6419%N/A
#4
$12.3M655%N/A
#5
$10.1M653%N/A